Sarepta Therapeutics (NQ: SRPT )
141.25
+3.97
(+2.89%)
Streaming Delayed Price
Updated: 12:34 PM EDT, Aug 20, 2024
Add to My Watchlist
Headline News about Sarepta Therapeutics
![](/next-assets/images/schema-image-default.png)
24 Analysts Have This to Say About Sarepta Therapeutics
June 06, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-biohavenpharma-01-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/734260/businessman-with-a-chart-looking-at-his-computer.jpg)
![](https://g.foolcdn.com/editorial/images/733830/woman-and-girl-talking-to-doctor-in-hospital-room-healthcare-medicine-insurance-mother-daughter.jpg)
![](https://g.foolcdn.com/editorial/images/733332/cancer-patient-flexing-muscle.jpg)
![](https://www.investors.com/wp-content/uploads/2020/09/Stock-Sarepta-Boston01-company.jpg)
![](https://g.foolcdn.com/editorial/images/732520/fda-blocks-in-hand.jpg)
![](https://g.foolcdn.com/editorial/images/732132/crashing-arrow.jpg)
![](https://cdn.pixabay.com/photo/2014/12/10/20/48/medic-563425_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/24/americas_car-mart_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/732725/downward-trend.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_7608.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Sarepta Therapeutics
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Sarepta Therapeutics Earnings Preview
May 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/15/venus_concept_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/12/srpt-stock.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/biotech_shutter.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/15/stock_market_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/sarepta_boston_232-2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/srpt.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/732401/dna-double-helix.jpg)
![](https://www.investors.com/wp-content/uploads/2020/09/Stock-Sarepta-Boston01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/10/srpt.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_837.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_824.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/19/screenshot_2023-04-19_at_6.36.02_pm.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.